gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund  asia today news  events   pr news events features eco  green education nonprofit innovation   log in register      event   listings   partners   newsletters   subscribe   submit event   submit news   search this site   gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund   jul   category investmentpr news gf securities gf xinde investment management co ltd gf xinde and bay city capital llc bay city capital in collaboration with the china society of biotechnology and the china pharmaceutical enterprises development promote association organized and hosted the th china biotechnology industry conference  the biomedical and health industry investment and financing summit forum the conference was held on july  and  in the guangzhou baiyun international convention center in guangzhou city china the theme of the conference focused on the globalization of chinas innovation and the internationalization of regulation in the biotechnology and biomedical industries in addition the conference covered the latest trends on crossborder biomedical investments and financings and bridging the technology gap between western technologies and domestic chinese innovation dr zeng hao chairman of gf xinde zhu xun director of the tongxieyi innovative drug club and david beier jd the managing director of bay city capital were in attendance at the conference during the twoday conference participants presented and exchanged opinions on chinese drug regulation in the new era strategies of major pharmaceutical companies in china and a review of biomedical investments and financings in the united states and europe also at the conference bay city capital and gf xinde announced a new life sciences fund  bay city capital gf xinde international life sciences usd fund lp a cayman islands exempted limited partnership this fund will invest in companies across all stages of development with a focus on novel and transformative biopharmaceutical investments including the united states canada western europe and china this unique collaboration between bay city capital and gf xinde aims to capitalize on the strengths of bay city capital in deal sourcing and execution in the western markets and gf xindes strategic network in china for valueadd partnerships and financing opportunities for the fund china is the fastest growing life science market and is the worlds second largest pharmaceutical market said david beier managing director of bay city capital our collaboration with gf xinde can provide valuable insights for this important healthcare segment gf xinde is a private equity investment subsidiary wholly owned by gf securities a large leading ah share listed securities company whose clients comprise  percent of the listed pharmaceutical companies in china and which has deep connections to chinese biotech and pharma industries the establishment of bay city capital gf xinde international life sciences usd fund is another important step in gf xindes china life science strategy access to innovation is a high priority for chinese companies and this fund will provide a window into cuttingedge technologies and assets in the united states and beyond and serve as a crossborder healthcare investment and technologylicensing portal for both foreign and chinese healthcare companies said dr zeng hao chairman of gf xinde this press release is issued by wonderful sky financial group limited on behalf of gf securities co ltd for further information please contact wonderful sky financial group limited ms jacqueline wong ms rose guo  mr terry zhu tel          fax    email powsfghk  gfswsfghk  asia today news global distribution httpwwwasiatodaycom   recent articles cdot launched the mass production of its first batch of full screen  module products nationwide eqs group opens up further growth potential with its new whistleblowing solution  expansion into the areas of governance risk  compliance grc cnit signs  million cloudbased ad terminal contract for beiijing laurel hill congratulates china biologic products inc for receiving overwhelming shareholder support for its redomicile from delaware to the cayman islands at the annual meeting union medical healthcare wins certificate of merit in enterprising hong kong brand awards  gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund tcl multimedia establishes crossboundary collaboration with tencent guotai junan international becomes one of the first overseas institutions in concluding the first domestic bond transaction through bond connect longitech smart energy disposing noncore businesses rapidly develops smart energy and solar energy businesses kerry logistics reaped two wins at  aflas awards named best pl and best logistics service provider  air freight   see all leading fintech firm to build top global mobile wallet clearance and settlement system jul   global industry gathering to be held in the world’s largest gas consuming and gas producing country jul   cdot launched the mass production of its first batch of full screen  module products nationwide jul   nkf malaysia holds th patient forum for dialysis patients  their caregivers jul   partsclean   right on track with new special exhibition and high exhibitor numbers jul   national challenges need for affordable and accessible homes take focus on the road to the th asiapacific housing forum jul   eqs group opens up further growth potential with its new whistleblowing solution  expansion into the areas of governance risk  compliance grc jul   cnit signs  million cloudbased ad terminal contract for beiijing jul   submit news or article about us contact us term of use publishers  partners promote events  branding resources     asia today       gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund  asia today news  events   pr news events features eco  green education nonprofit innovation   log in register      event   listings   partners   newsletters   subscribe   submit event   submit news   search this site   gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund   jul   category investmentpr news gf securities gf xinde investment management co ltd gf xinde and bay city capital llc bay city capital in collaboration with the china society of biotechnology and the china pharmaceutical enterprises development promote association organized and hosted the th china biotechnology industry conference  the biomedical and health industry investment and financing summit forum the conference was held on july  and  in the guangzhou baiyun international convention center in guangzhou city china the theme of the conference focused on the globalization of chinas innovation and the internationalization of regulation in the biotechnology and biomedical industries in addition the conference covered the latest trends on crossborder biomedical investments and financings and bridging the technology gap between western technologies and domestic chinese innovation dr zeng hao chairman of gf xinde zhu xun director of the tongxieyi innovative drug club and david beier jd the managing director of bay city capital were in attendance at the conference during the twoday conference participants presented and exchanged opinions on chinese drug regulation in the new era strategies of major pharmaceutical companies in china and a review of biomedical investments and financings in the united states and europe also at the conference bay city capital and gf xinde announced a new life sciences fund  bay city capital gf xinde international life sciences usd fund lp a cayman islands exempted limited partnership this fund will invest in companies across all stages of development with a focus on novel and transformative biopharmaceutical investments including the united states canada western europe and china this unique collaboration between bay city capital and gf xinde aims to capitalize on the strengths of bay city capital in deal sourcing and execution in the western markets and gf xindes strategic network in china for valueadd partnerships and financing opportunities for the fund china is the fastest growing life science market and is the worlds second largest pharmaceutical market said david beier managing director of bay city capital our collaboration with gf xinde can provide valuable insights for this important healthcare segment gf xinde is a private equity investment subsidiary wholly owned by gf securities a large leading ah share listed securities company whose clients comprise  percent of the listed pharmaceutical companies in china and which has deep connections to chinese biotech and pharma industries the establishment of bay city capital gf xinde international life sciences usd fund is another important step in gf xindes china life science strategy access to innovation is a high priority for chinese companies and this fund will provide a window into cuttingedge technologies and assets in the united states and beyond and serve as a crossborder healthcare investment and technologylicensing portal for both foreign and chinese healthcare companies said dr zeng hao chairman of gf xinde this press release is issued by wonderful sky financial group limited on behalf of gf securities co ltd for further information please contact wonderful sky financial group limited ms jacqueline wong ms rose guo  mr terry zhu tel          fax    email powsfghk  gfswsfghk  asia today news global distribution httpwwwasiatodaycom   recent articles cdot launched the mass production of its first batch of full screen  module products nationwide eqs group opens up further growth potential with its new whistleblowing solution  expansion into the areas of governance risk  compliance grc cnit signs  million cloudbased ad terminal contract for beiijing laurel hill congratulates china biologic products inc for receiving overwhelming shareholder support for its redomicile from delaware to the cayman islands at the annual meeting union medical healthcare wins certificate of merit in enterprising hong kong brand awards  gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund tcl multimedia establishes crossboundary collaboration with tencent guotai junan international becomes one of the first overseas institutions in concluding the first domestic bond transaction through bond connect longitech smart energy disposing noncore businesses rapidly develops smart energy and solar energy businesses kerry logistics reaped two wins at  aflas awards named best pl and best logistics service provider  air freight   see all leading fintech firm to build top global mobile wallet clearance and settlement system jul   global industry gathering to be held in the world’s largest gas consuming and gas producing country jul   cdot launched the mass production of its first batch of full screen  module products nationwide jul   nkf malaysia holds th patient forum for dialysis patients  their caregivers jul   partsclean   right on track with new special exhibition and high exhibitor numbers jul   national challenges need for affordable and accessible homes take focus on the road to the th asiapacific housing forum jul   eqs group opens up further growth potential with its new whistleblowing solution  expansion into the areas of governance risk  compliance grc jul   cnit signs  million cloudbased ad terminal contract for beiijing jul   submit news or article about us contact us term of use publishers  partners promote events  branding resources     asia today       gf xinde and bay city capital cohost investment conference and announce collaboration on unique fundhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listentop economists debate state of labor marketyahoo finances nicole sinclair moderates a panel of leading economists at the state of the labor market summitgf xinde and bay city capital cohost investment conference and announce collaboration on unique fundnewsfile corpnewsfilejuly  reblogsharetweetsharenew york new yorknewsfile corp  july    gf securities gf xinde investment management co ltd gf xinde and bay city capital llc bay city capital in collaboration with the china society of biotechnology and the china pharmaceutical enterprises development promote association organized and hosted the th china biotechnology industry conference  the biomedical and health industry investment and financing summit forum the conference was held on july  and  in the guangzhou baiyun international convention center in guangzhou city chinathe theme of the conference focused on the globalization of chinas innovation and the internationalization of regulation in the biotechnology and biomedical industries in addition the conference covered the latest trends on crossborder biomedical investments and financings and bridging the technology gap between western technologies and domestic chinese innovationdr zeng hao chairman of gf xinde zhu xun director of the tongxieyi innovative drug club and david beier jd the managing director of bay city capital were in attendance at the conferenceduring the twoday conference participants presented and exchanged opinions on chinese drug regulation in the new era strategies of major pharmaceutical companies in china and a review of biomedical investments and financings in the united states and europealso at the conference bay city capital and gf xinde announced a new life sciences fund  bay city capital gf xinde international life sciences usd fund lp a cayman islands exempted limited partnership this fund will invest in companies across all stages of development with a focus on novel and transformative biopharmaceutical investments including the united states canada western europe and china this unique collaboration between bay city capital and gf xinde aims to capitalize on the strengths of bay city capital in deal sourcing and execution in the western markets and gf xindes strategic network in china for valueadd partnerships and financing opportunities for the fund china is the fastest growing life science market and is the worlds second largest pharmaceutical market said david beier managing director of bay city capital our collaboration with gf xinde can provide valuable insights for this important healthcare segmentgf xinde is a private equity investment subsidiary wholly owned by gf securities a large leading ah share listed securities company whose clients comprise  percent of the listed pharmaceutical companies in china and which has deep connections to chinese biotech and pharma industries the establishment of bay city capital gf xinde international life sciences usd fund is another important step in gf xindes china life science strategy access to innovation is a high priority for chinese companies and this fund will provide a window into cuttingedge technologies and assets in the united states and beyond and serve as a crossborder healthcare investment and technologylicensing portal for both foreign and chinese healthcare companies said dr zeng hao chairman of gf xindethis press release is issued by wonderful sky financial group limited on behalf of gf securities co ltdfor further information please contactwonderful sky financial group limitedms jacqueline wong ms rose guo  mr terry zhutel         fax   email powsfghk  gfswsfghkreblogsharetweetsharerecently viewedyour list is emptywhat to read nextchina and india are edging closer to a war in asia that neither can back down frombusiness insider ukengineer finds pattern makes millions in stocksmoney morningsponsoredchinas army looks like its getting ready for something big to go down in north koreabusiness insider ukas india and china face off in the mountains a new confrontation is growing in the oceancnbcchina urges us to stop unfriendly recon flightsafpwomen everywhere should carry this tiny devicesiren songsponsoredchina is strengthening its military presence along the borders with north korea and indianewsweekkristin beck transgender navy seal hero lets meet face to face and you tell me im not worthybusiness insiderhighest ranking retired transgender officer slams new plan i think trump is ‘being influenced by pence’business insiderdiscover it  out of  avg by k customersdiscover cardsponsoredfacebook results beat estimates as mobile ad sales soar stock at record highreutersadvanced micro devices could gain another  within hours chartthe streetamazon’s echo rivaled by xiaomi and facebook rptyahoo finance videostart earning miles with the best travel cardwise breadsponsoredmoney basics what is a hedge fundyahoo financewhite house press secretary threatens to end briefing amid grilling over trumps transgender banbusiness insidersens mccain and ernst both veterans oppose trump’s ban on transgender military servicec americans should not have to pay for anyones reassignment surgery certainly not the militaryjoin the conversation  k   bay city capital gf xinde international life sciences usd fund lp  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money bay city capital gf xinde international life sciences usd fund lp funding details bay city capital gf xinde international life sciences usd fund lp industry pooled investment fundcik number irs number address ugland house po box  grand cayman kyphone number  bay city capital gf xinde international life sciences usd fund lp filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dyet to sellb c csec filing directors and executives of bay city capital gf xinde international life sciences usd fund lp key people in bay city capital gf xinde international life sciences usd fund lp na bay city capital gf xinde investment management codavid beierfrederick cravesxuesheng xiaoxiaomin aoyongyuan xie similar companiesbay pond partners lp bay equity llc bay national corp bay bridge tmt value fund lp baylake corp bayhill therapeutics inc bay view partners llc bayru llc bay state surgical services llc bayview opportunity domestic iia lp bayview opportunity offshore iia lp bay area partners ltd last visited companies washington economic recovery fund inc whippoorwill distressed opportunity fund l p whippoorwill offshore distressed opportunity fund ltd whitecliffempowermx lp adcore capital inc  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies bay city capital gf xinde international life sciences usd fund lp bizpediaxyz  we monitor changes in companies bizpediaxyz  we monitor changes in companies bay city capital gf xinde international life sciences usd fund lp free email watchdog get free email notifications about news in bay city capital gf xinde international life sciences usd fund lp the service is free and you can unsubscribe at any time general  people   filings   investment rounds  cik number irs number bay city capital gf xinde international life sciences usd fund lp is on the market less than  years bay city capital gf xinde international life sciences usd fund lp addressugland house po box grand cayman ky company jurisdiction cayman islands entity type cayman islands exempted limited partnership earliest known filing november  latest known filing november  company filings sec filings are a great source of information for companies including investments company events and all sorts of other information bay city capital gf xinde international life sciences usd fund lp has  filings view bay city capital gf xinde international life sciences usd fund lp filings investment roundsbay city capital gf xinde international life sciences usd fund lp recieved  investments peoplewe have found  people related to bay city capital gf xinde international life sciences usd fund lp similar companiesbay state gas co new baybanks inc bay area holdings inc baylake corp baytide securities corporation bayport restaurant group inc bay area bancshares bay commercial services bayou steel corp bay partners iv bay networks inc de baylake bank ta bay street associates ltd bay bancorp inc bayfunds bayfield low income housing limited partnership bay networks inc bayberry west partners l p bay resource partners lp baybank ma bay ridge bancorp inc bayview yacht club inc bay banks savings profit sharing  stock owership trust bayerische hypotheken und wechsel bank ag fi bayhawk ales inc bay area warehouse stores inc bayer ag fi bay pond partners lp baystate capital services inc baylor college of medicine bay commercial services employee stock ownership plan bayley frank s bay harbour  ltd bayou securities llc bd bay crest partners llc bayer corp bayside development corp bayview investors ltd baycorp holdings ltd bay isle financial corp bayer richard a baylor harold a jr bayless jon w bay view securitization corp baylor university medical center bayside financial corp bayern steven bayless jon w inc bay pond investors berumda l p bay banks of virginia inc bizpediaxyz collect news financial information sec filings stock information contact information personal information information about investments etc about bay city capital gf xinde international life sciences usd fund lp bay city capital gf xinde international life sciences usd fund lp  financing  newest sec filings newest filings bay city capital gf xinde international life sciences usd fund lp  financing bay city capital gf xinde international life sciences usd fund lp just submitted form d announcing  financing this is a new filing bay city capital gf xinde international life sciences usd fund lp was able to sell  that is  of the round of financing the total private offering amount was  the financing was made by  investors minimal accepted investment was  the financing document was filed on  bay city capital gf xinde international life sciences usd fund lp is based in ugland house po box  grand cayman ky the firms business is pooled investment fund the firms revenue range is decline to disclose the form was signed by na bay city capital gf xinde investment management co sec form d the securities and exchange commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and completethe reader should not assume that the information is accurate and complete united states securities and exchange commissionwashington dc form dnotice of exempt offering of securities omb approval omb number  estimated average burden hours per response   issuers identity cik filer id number previous names x none entity type     corporation    limited partnership    limited liability company    general partnership    business trust x other specify cayman islands exempted limited partnership name of issuer bay city capital gf xinde international life sciences usd fund lp jurisdiction of incorporationorganization cayman islands year of incorporationorganization    over five years ago x within last five years specify year     yet to be formed  principal place of business and contact information name of issuer bay city capital gf xinde international life sciences usd fund lp street address  street address  ugland house po box  city stateprovincecountry zippostalcode phone number of issuer grand cayman cayman islands ky   related persons last name first name middle name bay city capital gf xinde investment management co na na street address  street address   battery street suite  city stateprovincecountry zippostalcode san francisco california  relationship    executive officer    director x promoter clarification of response if necessary the general partner of the issuer last name first name middle name beier david william street address  street address   battery street suite  city stateprovincecountry zippostalcode san francisco california  relationship    executive officer x director x promoter clarification of response if necessary director of the general partner last name first name middle name craves frederick bernard street address  street address   battery street suite  city stateprovincecountry zippostalcode san francisco california  relationship    executive officer x director x promoter clarification of response if necessary director of the general partner last name first name middle name xiao xuesheng street address  street address  th floor no  tianhe north road tianhe district city stateprovincecountry zippostalcode guangzhou guangdong china  relationship    executive officer x director x promoter clarification of response if necessary director of the general partner last name first name middle name ao xiaomin street address  street address  th floor no  tianhe north road tianhe district city stateprovincecountry zippostalcode guangzhou guangdong china  relationship    executive officer x director x promoter clarification of response if necessary director of the general partner last name first name middle name xie yongyuan street address  street address  th floor no  tianhe north road tianhe district city stateprovincecountry zippostalcode guangzhou guangdong china  relationship    executive officer x director x promoter clarification of response if necessary director of the general partner  industry group    agriculture banking  financial services    commercial banking    insurance    investing    investment banking x pooled investment fund    hedge fund    private equity fund x venture capital fund    other investment fund is the issuer registered as an investment company under the investment company act of     yes x no    other banking  financial services    business services energy    coal mining    electric utilities    energy conservation    environmental services    oil  gas    other energy health care    biotechnology    health insurance    hospitals  physicians    pharmaceuticals    other health care    manufacturing real estate    commercial    construction    reits  finance    residential    other real estate    retailing    restaurants technology    computers    telecommunications    other technology travel    airlines  airports    lodging  conventions    tourism  travel services    other travel    other  issuer size revenue range or aggregate net asset value range    no revenues    no aggregate net asset value                                                    over     over  x decline to disclose    decline to disclose    not applicable    not applicable  federal exemptions and exclusions claimed select all that apply    rule b not i ii or iii    rule  bi    rule  bii    rule  biii    rule  x rule b    rule c    securities act section a x investment company act section c x section c    section c      section c    section c    section c    section c    section c    section c    section c    section c    section c    section c    section c  type of filing x new notice date of first sale x first sale yet to occur    amendment  duration of offering does the issuer intend this offering to last more than one year    yes x no  types of securities offered select all that apply    equity x pooled investment fund interests    debt    tenantincommon securities    option warrant or other right to acquire another security    mineral property securities    security to be acquired upon exercise of option warrant or other right to acquire security    other describe  business combination transaction is this offering being made in connection with a business combination transaction such as a merger acquisition or exchange offer    yes x no clarification of response if necessary  minimum investment minimum investment accepted from any outside investor  usd  sales compensation recipient recipient crd number x none associated broker or dealer x none associated broker or dealer crd number x none street address  street address  city stateprovincecountry zippostal code states of solicitation select all that applycheck “all states” or check individual states    all states    foreignnonus  offering and sales amounts total offering amount  usd or    indefinite total amount sold  usd total remaining to be sold  usd or    indefinite clarification of response if necessary  investors    select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors and enter the number of such nonaccredited investors who already have invested in the offering regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors enter the total number of investors who already have invested in the offering   sales commissions  finders fees expenses provide separately the amounts of sales commissions and finders fees expenses if any if the amount of an expenditure is not known provide an estimate and check the box next to the amount sales commissions  usd    estimate finders fees  usd    estimate clarification of response if necessary  use of proceeds provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers directors or promoters in response to item  above if the amount is unknown provide an estimate and check the box next to the amount  usd    estimate clarification of response if necessary the issuers general partner or its designee is entitled to a management fee payable by the issuersignature and submission please verify the information you have entered and review the terms of submission below before signing and clicking submit below to file this notice terms of submission in submitting this notice each issuer named above is notifying the sec andor each state in which this notice is filed of the offering of securities described and undertaking to furnish them upon written request in the accordance with applicable law the information furnished to offerees irrevocably appointing each of the secretary of the sec and the securities administrator or other legally designated officer of the state in which the issuer maintains its principal place of business and any state in which this notice is filed as its agents for service of process and agreeing that these persons may accept service on its behalf of any notice process or pleading and further agreeing that such service may be made by registered or certified mail in any federal or state action administrative proceeding or arbitration brought against it in any place subject to the jurisdiction of the united states if the action proceeding or arbitration a arises out of any activity in connection with the offering of securities that is the subject of this notice and b is founded directly or indirectly upon the provisions of  i the securities act of  the securities exchange act of  the trust indenture act of  the investment company act of  or the investment advisers act of  or any rule or regulation under any of these statutes or ii the laws of the state in which the issuer maintains its principal place of business or any state in which this notice is filed certifying that if the issuer is claiming a regulation d exemption for the offering the issuer is not disqualified from relying on regulation d for one of the reasons stated in rule biii or rule d each issuer identified above has read this notice knows the contents to be true and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person for signature type in the signers name or other letters or characters adopted or authorized as the signers signature issuer signature name of signer title date bay city capital gf xinde international life sciences usd fund lp s frederick bernard craves frederick bernard craves director of the general partner  persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb number  this undertaking does not affect any limits section a of the national securities markets improvement act of  nsmia pub l no   stat  oct   imposes on the ability of states to require information as a result if the securities that are the subject of this form d are covered securities for purposes of nsmia whether in all instances or due to the nature of the offering that is the subject of this form d states cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent nsmia permits them to do so under nsmias preservation of their antifraud authority bay city capital gf xinde international life sciences usd fund lp financing datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dyet to sellb c cview bay city capital gf xinde international life sciences usd fund lp list of executivesdavid beier frederick craves na bay city capital gf xinde investment management co xiaomin ao xuesheng xiao yongyuan xie last visited elementum directus onshore fund lp elevation real property fund v llc elicit inc elk homes partners ii lp ellipsis technologies inc  bay city capital gf xinde international life sciences usd fund lp  pooled investment fund ao formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local bay city capital gf xinde international life sciences usd fund lp industry pooled investment fund see others in industry address ugland house po box  grand cayman e kyphone  filings date filingtype reported sold incremental cash type exemptions link to raw filing  new yet to sell  other b c c sec link directors and executives current and past name role xiaomin ao director promoter na na bay city capital gf xinde investment management co promoter david william beier director promoter frederick bernard craves director promoter xuesheng xiao director promoter yongyuan xie director promoter bay city capital gf xinde international life sciences usd fund lp  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors bay city capital gf xinde international life sciences usd fund lp list of persons related to the company bay city capital gf xinde international life sciences usd fund lp find out list of ceos founders board members and company directors of bay city capital gf xinde international life sciences usd fund lp cik number irs number company address ugland house po box  grand cayman kyphone number  people related to bay city capital gf xinde international life sciences usd fund lp namepositionstreetcitycountrywilliam beier david battery street suite san franciscocab craves frederick battery street suite san franciscocana bay city capital gf xinde investment management co na battery street suite san franciscocaao xiaominth floor no  tianhe north road tianhe districtguangzhou guangdongchinaxiao xueshength floor no  tianhe north road tianhe districtguangzhou guangdongchinaxie yongyuanth floor no  tianhe north road tianhe districtguangzhou guangdongchina bay city capital gf xinde international life sciences usd fund lp on the web related companiesbay acquisition corp bay area  pacific coast development limited partnership bay area  pacific coast development inc bay area  fund llc bay area  fund llc bay area accountable care network inc bay area hospital real estate llc bay area partners ltd bay area regional medical center llc bay avenue longshort investment fund i llc bay avenue private opportunities fund llc bay bancorp inc bay banks of virginia inc bay bridge tmt value fund lp bay capital feeder fund ltd gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund         homenewsfilexbrlprintingabout newsfilecareerscontactfrançais     gf xinde and bay city capital cohost investment conference and announce collaboration on unique fund new york new yorknewsfile corp  july    gf securities gf xinde investment management co ltd gf xinde and bay city capital llc bay city capital in collaboration with the china society of biotechnology and the china pharmaceutical enterprises development promote association organized and hosted the th china biotechnology industry conference  the biomedical and health industry investment and financing summit forum the conference was held on july  and  in the guangzhou baiyun international convention center in guangzhou city chinathe theme of the conference focused on the globalization of chinas innovation and the internationalization of regulation in the biotechnology and biomedical industries in addition the conference covered the latest trends on crossborder biomedical investments and financings and bridging the technology gap between western technologies and domestic chinese innovationdr zeng hao chairman of gf xinde zhu xun director of the tongxieyi innovative drug club and david beier jd the managing director of bay city capital were in attendance at the conferenceduring the twoday conference participants presented and exchanged opinions on chinese drug regulation in the new era strategies of major pharmaceutical companies in china and a review of biomedical investments and financings in the united states and europealso at the conference bay city capital and gf xinde announced a new life sciences fund  bay city capital gf xinde international life sciences usd fund lp a cayman islands exempted limited partnership this fund will invest in companies across all stages of development with a focus on novel and transformative biopharmaceutical investments including the united states canada western europe and china this unique collaboration between bay city capital and gf xinde aims to capitalize on the strengths of bay city capital in deal sourcing and execution in the western markets and gf xindes strategic network in china for valueadd partnerships and financing opportunities for the fund china is the fastest growing life science market and is the worlds second largest pharmaceutical market said david beier managing director of bay city capital our collaboration with gf xinde can provide valuable insights for this important healthcare segmentgf xinde is a private equity investment subsidiary wholly owned by gf securities a large leading ah share listed securities company whose clients comprise  percent of the listed pharmaceutical companies in china and which has deep connections to chinese biotech and pharma industries the establishment of bay city capital gf xinde international life sciences usd fund is another important step in gf xindes china life science strategy access to innovation is a high priority for chinese companies and this fund will provide a window into cuttingedge technologies and assets in the united states and beyond and serve as a crossborder healthcare investment and technologylicensing portal for both foreign and chinese healthcare companies said dr zeng hao chairman of gf xindethis press release is issued by wonderful sky financial group limited on behalf of gf securities co ltdfor further information please contactwonderful sky financial group limitedms jacqueline wong ms rose guo  mr terry zhutel         fax   email powsfghk  gfswsfghk follow newsfilecorp jyn erso  🇺🇸jynerso  s disciple rdresist ezrabridger theswprincess morethanmysle minervasbard jetpaxndemocrac… httpstcobtfhrrcsj james pollardjamespollard  s the military is here for war and defense the military hasnt cared for feelings since  🇺🇸 roughsoulroughsoul  m rt dailycaller court docs imran awan allegedly threatened to kidnap stepmother’s relatives if she spoke to cops httpstcobmafewpl… companys news releases gf xinde and bay city capital cohost investment conference and announce collaboration on unique fundgf securities dynamic globalization strategy visit companys profile page copyright  newsfile corp all rights reserved terms and conditions of use  privacy policy  antispam policy  contact us gf securities dynamic globalization strategy gf xinde establishes life sciences fund in the us  dgapde mywatchlist login  kontakt   realtime mitteilungen kurse  charts unternehmenscenter research erweiterte suche mywatchlist die dgap   alle adhocmitteilungen weitere unternehmensmitteilungen übernahmeangebote directors dealings stimmrechtsanteile gesamtstimmrechte hvbekanntmachungen vorabbekanntmachung finanzberichte sonstige kapitalmarktinformationen zwischenmitteilungen uk regulatory internationale news     gf securities co ltd hk gf securities co ltd hk isin cnetq land china nachricht vom    gf securities dynamic globalization strategy gf xinde establishes life sciences fund in the us eqsnews     utc new york us may    gf securities dynamic globalization strategy gf xinde establishes life sciences fund in the us recently at new york times square the gf securities th anniversary promo video is airing on the china billboard downtown  times a day gf securities is the largest nongovernment investment bank in china listed on the shenzhen and hk stock exchanges in february  and april  respectively the promotional display at times square in new york city is not only to create momentum for gf xinde investment management co ltd a wholly owned subsidiary of gf securities hereinafter referred to as gf xinde and to celebrate the creation of a life sciences fund in the us furthermore it represents gf securities overall strategic layout to acquire diversified assets including cuttingedge technology laying a solid foundation for the companys overall strategy of increased globalization on may  edt gf xinde signed a strategic cooperation agreement in new york with bay city capital americas leading life sciences investment institution for initiating the establishment of a multinational life sciences fund mr sun shuming chairman of gf securities attended the ceremony and declared that this life sciences fund is the first investment fund that combines international technology and chinese backing this investment platform aims to break through innovative medical deficiencies in china with advancements in life sciences technology representing a new era of creation and innovation with more than  years of strategic planning and development the pace of gf securities international investments are gaining greater and greater traction this is an unprecedented breakthrough in healthcare for gf securities to establish an international life sciences fund with the leading life sciences investment institution in the united states it will provide momentum and innovative development resources for the chinese life sciences industry in terms of crossindustry and crossborder cooperation this fund is an innovative first amongst chinese investment banks mr fred craves founder and managing partner of bay city capital was in attendance during the ceremonial signing and remarked bay city capital has invested in life sciences technology for nearly  years and we feel honored to partner with gf securities and gf xinde we have been interested with great intensity in the chinese markets closely following the initiatives put forth by the chinese government for improving the quality and accessibility of universal health care the current speed of development in chinas pharmaceutical industry is much higher than that of europe and america thus the country is expected to become the worlds largest pharmaceutical market soon this will provide many opportunities for international medical investment institutions to enter china gf securities as one of chinas leading investment banks has a wealth of resources and experience in capital market operations with a vast network of institutional clients we are confident that the cooperation between gf xinde and bay city capital in an international life sciences fund will create outstanding financial and industrial benefits for chinese enterprises the fund jointly managed by gf xinde and bay city capital focuses on investing in innovative life science companies with high growth potential in the united states europe and china the fund will be fully backed by the resources of both bay city capital and gf xinde to achieve crossborder mergers and acquisitions which will serve to introduce the worlds leading technology to chinese enterprises chinese companies will gain access to competitive global products and technology the fund will diversify sources of returns through a variety of exits channels through crossborder mergers and acquisitions and the licensing of technology gf securities and bay city capital have already attracted large publicly listed pharmaceutical enterprises to be limited partners including by health jinling aodong nanjing pharma and nanjing new industry investment group which is major shareholder of jinling pharma as well as publicly listed companies and institutions such as solareast and hengqin financial investment there is a lack of leadingedge technology and innovative diversity in the pharmaceutical industry of china in order to meet the demand for overseas mergers and acquisitions now is a crucial time for chinese pharmaceutical enterprises to carry out a largescale reform of the pharmaceutical industry in china strong reform and supply side development in this industry will have profound social effects for the entire chinese society gf xinde is chinas leading pe and vc investment institution in china since its establishment over the past eight years the company has ranked top three for direct investment five years in a row assets under management are more than rmb  billion specializing in vc investment in life sciences listed pharmaceutical companies crossborder investment banking ipo and m  as in the field of life sciences gf xinde and gf securities has a team of over  investment advisors investment bankers and equity analysts in addition gf xinde has a large presence in the health and medical industries not only through direct investment holdings but facilitating merger and acquisitions of hospitals in china and investing a considerable amount in various life sciences companies gf xinde has over  projects underway in the field of life science and the gf xinde medical treatment industry ma fund focuses on mergers and acquisitions of hospitals with over  potential acquisition targets each year bay city capital has been deeply involved in life sciences investment for over  years in the united states of america it is the worlds leading life sciences vc investment institution with a wealth of experience and resources in the rd of pharmaceuticals and medical devices ipos and mas scientists and entrepreneurs the company has invested in more than  life sciences companies worldwide with a successful exit rate of more than  end this press release is issued by wonderful sky financial group limited on behalf of gf securities co ltd for further information please contact wonderful sky financial group limited connie liu  barney liu sindy wong tel  （） （）  email powsfghk  barneyliuwsfghk  sindywongwsfghk document httpneqscomcfnclssspuxchafsqxkvdocument title gf securities dynamic globalization strategy gf xinde establishes life sciences fund in the us key words miscellaneous  dissemination of a press release transmitted by eqs todayir  a company of eqs group agthe issuer is solely responsible for the content of this announcementmedia archive at wwwtodayircom kurschart kursdetails anzeigen interaktiv weitere unternehmensdetails news per mail erhalten news aufs handy erhalten news empfehlen news drucken dgapwatchlist email passwort passwort vergessen   zur registrierung übersicht indizes weitere indizes weitere news weitere news anzeigen gbc im fokus fintechspezialist für den afrikanischen markt das fintechunternehmen mybucks sa bietet den kunden aus der subsahararegion durch den einsatz moderner technologien einen zugang zu finanzprodukten und dienstleistungen hierbei handelt es sich in erster linie um nicht besicherte kredite welche über onlinekanäle beantragt und in anspruch genommen werden die grundlage für die geschäftstätigkeit stellt die selbstentwickelte technologie dar wodurch kunden innerhalb weniger minuten eine kreditentscheidung erhalten wir gehen von einer fortsetzung der dynamischen unternehmensentwicklung aus und haben einen fairen wert von  € je aktie und damit hohes kurspotenzial ermittelt wir vergeben das rating kaufen zur studie der aktionär news juli  neue ausgabe bis zu  mit blue chips heiße optionsscheinwetten  juli  barrick gold newmont und co vor dem comeback juli  amd bringen die quartalszahlen den turnaround juli  hackeralarm bei unicredit –  kunden betroffen juli  commerzbank das ist der knaller news im fokus allianz se allianz gruppe steigert im q  operatives ergebnis um  prozent aufgrund von verbesserungen in allen geschäftsbereichen operatives ergebnis des gesamtjahres wird voraussichtlich das obere ende der avisierten zielspanne erreichen  juli   zur meldung aktuelle researchstudie originalresearch solutions  se von sphene capital gmbh buy solutions  se  juli  zur researchstudie   dgap – ein service der eqs group ag twitter  impressum  agb  rechtliche hinweise  datenschutz